Merck KGaA

Merck KGaA to cut costs, jobs
Reuters
Fri, 02/24/12 - 03:16 pm
layoffs
Merck KGaA
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Sat, 02/4/12 - 05:01 pm
Threshold Pharmaceuticals
Merck KGaA
TH-302
sarcoma
pancreatic cancer
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tue, 12/20/11 - 10:23 am
Sanofi
MS
Aubagio
Rebif
multiple sclerosis
Merck KGaA
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
Facebook apologizes for Merck homepage mix-up
Reuters
Mon, 11/28/11 - 04:42 pm
Facebook
Merck
social media
Merck KGaA
Merck said to hijack German rival's Facebook page
Yahoo/Reuters
Wed, 11/23/11 - 10:39 am
Merck
Merck KGaA
Facebook
Merck KGaA Advances Most Since 2009 as Profit Beats Estimates
Bloomberg
Wed, 10/26/11 - 10:41 am
Merck KGaA
earnings
Merck KGaA, Ono Pharma Collaborate
Yahoo/Zacks
Sat, 10/15/11 - 11:34 am
Merck KGaA
Ono Pharmaceutical
ONO-4641
multiple sclerosis
Stimuvax
non-small cell lung cancer
Idera Pharmaceuticals says partner Merck KGaA will discontinue study of cancer drug
Yahoo/AP
Fri, 07/8/11 - 09:22 am
Idera Pharmaceuticals
Merck KGaA
cancer
It May Be Time to Throttle Back on Oncothyreon
Seeking Alpha
Mon, 06/27/11 - 09:27 am
Oncothyreon
Dendreon
ImmunoCellular
Merck KGaA
With cladribine gone, Gilenya takes center stage
Fierce Pharma
Wed, 06/22/11 - 07:35 pm
Gilenya
cladribine
Movectro
MS
multiple sclerosis
Novartis
Merck KGaA
Merck KGaA Slides After Decision Not to Seek MS Drug Approval
Bloomberg
Wed, 06/22/11 - 08:16 am
MS
multiple sclerosis
Merck KGaA
cladribine
Merck KGaA Beats, Raises Outlook
Yahoo/Zacks.com
Thu, 04/28/11 - 10:00 pm
earnings
Merck KGaA
Merck KGaA tries again on Erbitux for lung cancer
Fierce Pharma
Wed, 03/30/11 - 04:47 pm
Merck KGaA
lung cancer
Erbitux
Merck KGaA Seeks Fix for ‘Bunker’ Culture to Woo Investors
Bloomberg
Thu, 03/10/11 - 10:20 am
Merck KGaA
Merck KGaA Drug Fails to Convince FDA
WSJ Online
Wed, 03/2/11 - 11:56 am
Merck KGaA
FDA
cladribine
MS
multiple sclerosis
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
Merck KgaA, Lead Discovery Centre enter agreement for anti-cancer compounds discovery
Pharmabiz
Sat, 01/22/11 - 10:58 am
Merck KGaA
Lead Discovery Centre GmbH
Kinase
cancer

Pages